Meeting
2023 ASCO Annual Meeting
Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis.
Authors
Emily Harrold
Memorial Sloan Kettering Cancer Center, New York, NY
Emily Harrold , Henry S. Walch , Walid Khaled Chatila , Yelena Kemel , Matilde Borio , Anna Maio , Aliya Khurram , Erin E. Salo-Mullen , Alicia Latham , Yonina R. Murciano-Goroff , Kenneth Offit , Neil Howard Segal , Michael Bonner Foote , Leonard B. Saltz , Rona Yaeger , Nikolaus Schultz , Diana Mandelker , Andrea Cercek , Zsofia Kinga Stadler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10595)
DOI
10.1200/JCO.2023.41.16_suppl.10595
Abstract #
10595
Poster Bd #
228
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian